Axumin PET Scans: A Breakthrough for Prostate Cancer

Axumin is an FDA-approved, Medicare-covered scan that can achieve early detection of recurrent prostate cancer after surgery or radiation. For years we have been able to detect prostate cancer recurrences with PSA, but standard body and bone scans have been unable to determine the location of the cancer until the PSA level is excessively elevated (10 to 30 or higher).

Axumin can detect recurrent disease with PSA levels less than 10 and sometimes much lower, which is the reason this scan is such an important development. READ THE FULL ARTICLE HERE >

9 thoughts on “Axumin PET Scans: A Breakthrough for Prostate Cancer

    • Prostate Oncology Post authorReply

      Indication: Axumin® (fluciclovine F 18) injection is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment. You may find a list of facilities here:

  1. Steve Phelps Reply

    I have not had a prostate cancer diagnosis, only slowly elevating PSA. My current PSA is 5.6. Is the Axium Scan appropriate for Me? (I wanted to avoid biopsy.) Please let Me know.

    • Niv Reply

      If you had any radiation treatment or prostate surgery and your last 2 or3 Psa continues to raise you qualify

      Speak to your oncologist

    • roger Reply


      Please do a biopsy. My PSA was 5.5 and I did the biopsy. Out of 12 samples, 7 contained cancer cells ranging from Gleason score 6, 7, and one at 9. CT scan revealed prostate cancer cells went to a spot on the pelvis. Getting a PET scan next week to see if the cancer cells went anywhere else. Will begin hormone therapy and radiation. Don’t fool around with it! PSA is not the be all indicator. Biopsy is the solution for information.

  2. Steve Phelps Reply

    Where is the Axium Scan offered? A friend said UCLA Med. Center at a cost of $2,000.00. I have Medicare under United Health Care System. Would this be covered? Thanks for Your response.

  3. Prostate Oncology Post authorReply

    There are two different ways to do a prostate biopsy – targeted and random. The random 12-core prostate biopsy is standard and has been in use for over 25 years. Now, since MRI imaging has greatly improved, the number of needle biopsies can be reduced substantially. A couple of cores can be directed at a single target within the gland. There are pros and cons with a targeted biopsy. The first concern is that perhaps 10% of small, high-grade cancers can be missed by modern scanning. READ THE FULL ARTICLE HERE > https://WWW.VERYWELL.COM/IS-IT-POSSIBLE-TO-SUBSTITUTE-A-SCAN-FOR-PROSTATE-BIOPSY-2782279

Leave a Reply

Your email address will not be published. Required fields are marked *